Medullary thyroid carcinoma (MTC) · None
Deterministic view of the source YAML entity. Clinical authority remains with the cited source IDs and reviewer sign-off state.
Knowledge-base record for audit. Provisional clinical content: this is not a prescription. An oncologist must verify original sources, applicability and review status. Full rules and constraints are in the YAML.
| Track | standard |
|---|---|
| Linked regimen | None |
| ID | IND-MEN2-SUSPICION-PREVENTION-GENETIC-COUNSELING |
|---|---|
| Type | Indication |
| Status | reviewed 2026-05-18 | pending_clinical_signoff |
| Diseases | DIS-MTC |
| Sources | SRC-ATA-THYROID-2015 SRC-NCCN-THYROID-2025 |
Notes
STUB — v0.2-B hereditary pilot (MEN2, additional). ATA 2015 Revised Guidelines for the Management of MTC (Wells et al., Thyroid 2015) is the central source for RET-class-driven prophylactic thyroidectomy timing. Two-Co-Lead signoff queued.
Used By
Red flag
RF-MEN2-FAMILY-HISTORY-SUSPICION- Family pedigree suggestive of Multiple Endocrine Neoplasia type 2 (MEN2A or MEN2B, RET-dr...